Sign in

CIK 0001719714

  • Non-accelerated filer
  • Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 3330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-26 Bender Jeremy Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Bender Jeremy Director Grant or award · Deferred Restricted Stock Units +117,533 117,533
2026-02-26 Jenkins Annalisa Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Jenkins Annalisa Director Grant or award · Deferred Restricted Stock Units +106,848 106,848
2026-02-26 Jacquet Pierre Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Jacquet Pierre Director Grant or award · Deferred Restricted Stock Units +106,848 106,848
2026-02-26 Yoskowitz Marc J Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Yoskowitz Marc J Director Grant or award · Deferred Restricted Stock Units +96,163 96,163
2026-02-26 Shames Daniel Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Shames Daniel Director Grant or award · Deferred Restricted Stock Units +96,163 96,163
2026-02-26 Ekblom Anders Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 Ekblom Anders Director Grant or award · Deferred Restricted Stock Units +133,560 133,560
2026-02-26 PAKIANATHAN DEEPIKA Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-26 WYZGA MICHAEL S Director Grant or award · Share Options (Right to buy) +66,000 66,000
2026-02-01 Lewicki John A. Chief Scientific Officer Grant or award · Share Options (Right to buy) +139,913 139,913
2026-02-01 Lewicki John A. Chief Scientific Officer Grant or award · Share Options (Right to buy) +46,637 46,637
2026-02-01 Lewicki John A. Chief Scientific Officer Grant or award · Share Options (Right to buy) +145,000 145,000
2026-02-01 Hughes-Wilson Alexandra See Remarks Grant or award · Share Options (Right to buy) +183,750 183,750
2026-02-01 Hughes-Wilson Alexandra See Remarks Grant or award · Share Options (Right to buy) +61,250 61,250
2026-02-01 Hughes-Wilson Alexandra See Remarks Grant or award · Share Options (Right to buy) +195,000 195,000

Page 1 of 7 · 139 trades